AlphAIAlphAI — Financial news for AI agents
Zacks CommentaryNOV 102 min read$DCGO

DocGo Inc. (DCGO) Reports Q3 Loss, Beats Revenue Estimates

Motion Acquisition (DCGO) delivered earnings and revenue surprises of -22.22% and +0.59%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Original reporting
Zacks Commentary · Zacks Equity Research
Published Nov 10, 2025, 10:40 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 11, 2025, 1:01 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
DocGo Inc. (DCGO) Reports Q3 Loss, Beats Revenue Estimates — source image
Source · www.zacks.com
Decision brief

The 30-second read

$DCGONeutralLow
01

Why it matters

The earnings report's mixed results and neutral market sentiment suggest limited immediate trading opportunities, with a focus on watching for future catalysts.

02

Market read

The news has limited impact on the broader market but may influence short-term trading decisions for DocGo Inc. and related sectors.

03

What to watch

Broader industry trends and upcoming catalysts could influence stock movement beyond the immediate earnings report.

Timing: short-term

Background

DocGo Inc. reported a Q3 loss but narrowly beat revenue estimates, reflecting mixed financial performance amid challenging market conditions.

Company-level read

Ticker impact

$DCGONeutralMedium confidence
Context

Primary focus due to recent earnings report.

Expected impact

Minimal short-term price movement expected; potential for sideways trading.

Evidence & confidence

The earnings report shows a loss with a slight revenue beat, leading to a neutral market reaction. The low relevance score (0.1389) indicates limited impact on broader market or industry trends.

Market effects

Sector

Limited sector impact; the healthcare and transportation sectors may experience negligible effects.

Regional

No significant regional market influence expected.

Global

Minimal global market relevance; company-specific news.

Counterpoint

What could challenge this read

The slight revenue beat could signal underlying strength, potentially leading to a positive reevaluation in the future.

Key entities

  • Company
    DocGo Inc.

    A healthcare services provider involved in medical transportation and related services.

Read at source← All news

Related articles

AUG 20
Med

DocGo Inc. Q2 2026 Earnings Call Summary

DocGo Inc. reported Q2 2026 earnings, highlighting a 19% year-over-year revenue increase in core business lines, despite a $6.3M adjusted EBITDA loss. The company announced its largest acquisition, Hicuity Health, aiming to integrate hospital and home care. Management expects to achieve positive adjusted EBITDA by year-end 2026, with revenue guidance narrowed to $305M-$310M. Cost synergies and efficiency programs are expected to drive future growth.

yahoo.com2 min
AUG 19
$DCGOMed

DocGo Shares Tumble After Earnings Miss and Wider Loss Forecast

DocGo (DCGO) shares fell 12.7% pre-market Tuesday after Q2 2026 earnings missed estimates, with a $0.16 loss per share vs. expected $0.10. Revenue was $73.4M, down 8.7% YoY, and the company widened its full-year adjusted EBITDA loss forecast to $17M-$22M. The decline followed the end of migrant-related contracts, though core revenue grew 19%. The stock trades near its 52-week low of $0.451.

yahoo.com2 min
AUG 19
$DCGOMed

DocGo Q2 Earnings Call Highlights

DocGo reported record service volumes in Q2, with year-over-year growth across all core businesses. The company acquired Hicuity, assuming $52M in debt and issuing 2% equity. DocGo's revenue rose to $52M in medical transportation but fell in mobile health due to migrant-related work decline. Adjusted EBITDA loss narrowed to $6.3M. The company updated its full-year outlook, expecting a wider EBITDA loss of $17M-$22M. DocGo has $48.1M in cash and expects positive adjusted EBITDA run rate by year-e

yahoo.com3 min
AUG 19
$DCGOMed

DocGo Inc (DCGO) (Q2 2026) Earnings Call Highlights: Record Volumes and Strategic

DocGo Inc (DCGO) reported Q2 2026 revenue of $73.4M, down from $80.4M YoY, and widened its adjusted EBITDA loss guidance to $17M-$22M. Gross margins declined due to lower margins in the Mobile Health segment and higher fuel costs. The company's cash position decreased to $48.1M. The Hicuity acquisition faces regulatory and customer approval hurdles. Organic revenue grew approximately 5% YoY. The company aims to achieve adjusted EBITDA breakeven by the end of 2026 through revenue growth, improved

yahoo.com7 min
AUG 18
$DCGOHighAI 9/10

Why is DocGo stock tumbling today?

DocGo (DCGO) shares fell 12.7% pre-open to $0.62 after its Q2 2026 adjusted loss was $0.16 per share versus $0.10 consensus. Revenue was $73.4M, below $75.4M forecast and down 8.7% YoY, tied to wind-down of migrant contracts. It widened FY2026 adjusted EBITDA loss to $17M-$22M and agreed to acquire Hicuity Health (~$65M trailing revenue).

investing.com4 min